Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07215845 · ClinicalTrials.gov registry record · NA
Pars Healing on MRI
A NA study of Pars Interarticularis Stress Fracture and Pars Interarticularis Stress Injury, sponsored by University of Missouri-Columbia.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT07215845: Recruiting NA study of Pars Interarticularis Stress Fracture and Pars Interarticularis Stress Injury, sponsored by University of Missouri-Columbia.
NCT07215845 is a NA study of Pars Interarticularis Stress Fracture and Pars Interarticularis Stress Injury that is actively recruiting participants, run by University of Missouri-Columbia. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07215845, a NA study of Pars Interarticularis Stress Fracture and Pars Interarticularis Stress Injury, is actively recruiting participants, sponsored by University of Missouri-Columbia.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to learn more about the natural healing process of pars stress injuries in adolescents and young adults by documenting bony bridging across stress fractures using Magnetic Resonance Imaging (MRI). It is hypothesized that many of these injuries can and will heal with appropriate rest and rehabilitation. Long-term, it is hoped that follow-up MRI exams can help guide clinical management by visualizing the healing and allowing individuals to return to play after bony bridging has occurred. Participants will be asked to undergo serial MRI scans over the course of a 12-month period and answer a brief questionnaire at each visit.
Primary Outcome
Stress injuries (fracture line and/or bone marrow edema) identified prior to study enrollment via initial clinical MRIs will be followed over serial research MRIs at 2 months, 4 months, 6 months, and 12 months after initial clinical MRI was completed. At each MRI, the fracture morphology (incomplete vs complete), bony bridging across any fracture line previously seen, amount of sclerosis, and presence of bone marrow edema will be described to assess degree of injury healing. Patient questionnair
Conditions Studied
Interventions
- DEVICE MRI
Study Locations (1)
Missouri
- University of Missouri - Columbia - Columbia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-12-12 |
| Est. Completion | 2028-12-31 |
| Phase | NA |
What NCT07215845 shows while recruiting
NCT07215845 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 2 conditions, with Pars Interarticularis Stress Fracture appearing as the primary indexed condition, and to 1 intervention - of which MRI is the first listed.
NCT07215845 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT07215845 about?
NCT07215845 is a clinical study titled "Pars Healing on MRI". The goal of this clinical trial is to learn more about the natural healing process of pars stress injuries in adolescents and young adults by documenting bony bridging across stress fractures using Magnetic Resonance Imaging (MRI). It is hypothesized that many of these injuries can and will heal wit...
What is the current status of trial NCT07215845?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-12-12. Estimated completion is 2028-12-31.
What conditions does trial NCT07215845 study?
This clinical trial studies the following conditions: Pars Interarticularis Stress Fracture, Pars Interarticularis Stress Injury.
What interventions are being tested in trial NCT07215845?
The interventions under investigation include: MRI (DEVICE).
Who is sponsoring clinical trial NCT07215845?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07215845 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07215845's enrollment target sits among peer trials
40 1448th of 2000 higher than 465 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI